Simparica Trio is one of the most prescribed parasite prevention medications in the United States — and one of the most misunderstood. Dog owners frequently don’t know what’s actually in it, which parasites it covers and which it doesn’t, what the FDA’s neurological warning really means for their dog, or why the vet doesn’t just let them buy it without an exam. This guide answers all of that, without pulling punches.
Dog owners searching for Simparica Trio typically have urgent, specific questions. These are the most common ones — answered plainly.
- 1 What exactly does Simparica Trio protect against? Simparica Trio provides six-way protection in a single monthly chew: it prevents heartworm disease (Dirofilaria immitis), kills adult fleas and prevents re-infestation, treats and controls five tick species, and treats and controls roundworm and hookworm infections. The five tick species it covers are the lone star tick, Gulf Coast tick, American dog tick, black-legged tick (deer tick), and brown dog tick. It does not cover tapeworms (you’d need a product containing praziquantel for those), whipworms, or ear mites.
- 2 Is Simparica Trio safe? What is the FDA neurological warning about? The FDA considers Simparica Trio safe and effective — but it has issued a public alert about the isoxazoline drug class (which includes sarolaner, the tick-and-flea ingredient) and its association with neurological adverse reactions in some dogs. These reactions can include muscle tremors, ataxia (loss of coordination), and seizures. Importantly, these events were not observed in Simparica Trio’s approval studies — the warning is a class-wide alert based on post-market reporting. Most dogs tolerate it without any neurological effects. Dogs with a prior history of seizures or neurological conditions warrant a specific conversation with your vet before starting.
- 3 Why does my vet require a heartworm test before prescribing it? Starting any heartworm preventative in a dog that already has adult heartworms can cause dangerous, potentially fatal complications. Moxidectin (one of Simparica Trio’s ingredients) has microfilaricidal activity — meaning it kills heartworm larvae (microfilariae) circulating in the blood. In a heavily infected dog, a sudden die-off of microfilariae can trigger a severe systemic inflammatory response similar to anaphylaxis. Your vet is not just covering administrative bases; this is a genuine clinical precaution. A negative test clears the path safely.
- 4 How quickly does it start killing fleas and ticks? Simparica Trio starts killing fleas within four hours of administration, achieving 100% effectiveness against existing flea infestations by eight hours in study conditions. Against ticks, it reached 98% control of an existing infestation by 12 hours post-treatment in one published study. Nine out of ten dogs voluntarily ate the chewable in palatability studies — a meaningful detail if you’ve ever fought a dog to take medication. It’s given once a month, with or without food, and protection lasts through day 35 based on study data.
- 5 Can I give Simparica Trio to my cat? No — Simparica Trio is approved for dogs only and is not safe for cats. All three active ingredients are toxic to cats in the doses formulated for dogs. Moxidectin and sarolaner both have neurotoxic effects in cats at canine dosing levels. In multi-pet households, the chewable tablet should be given directly to the dog and kept out of reach of cats — the liver-flavored chew is appealing to cats as well as dogs. If a cat ingests a Simparica Trio tablet, contact a veterinarian or the ASPCA Animal Poison Control Center (888-426-4435) immediately.
- 6 Does Simparica Trio work on heartworm-resistant strains? Yes — this is one of Simparica Trio’s most clinically significant advantages over ivermectin-based products. A published laboratory study tested six consecutive monthly doses against the ZoeLA macrocyclic lactone-resistant heartworm strain. Simparica Trio achieved 97.2% efficacy. In the same study, Heartgard Plus (ivermectin) achieved only 8.5% and Interceptor Plus (milbemycin oxime) achieved 35.9%. The difference is the moxidectin component — moxidectin belongs to a different subclass of macrocyclic lactones than ivermectin and appears to retain efficacy against resistant strains at the doses used in Simparica Trio.
- 7 Is it safe for herding breeds like Collies or Australian Shepherds? This is a legitimate concern that your vet must evaluate for your specific dog. Herding breeds including Collies, Border Collies, Australian Shepherds, and Shetland Sheepdogs are commonly affected by the MDR1/ABCB1 gene mutation, which impairs P-glycoprotein function at the blood-brain barrier. Moxidectin — a macrocyclic lactone — is a known P-glycoprotein substrate, meaning mutant dogs cannot effectively pump it out of the central nervous system, increasing neurotoxicity risk. Zoetis has conducted safety testing in herding breeds, but a genetic test for the ABCB1 mutation is worth discussing with your vet before starting moxidectin-containing products in these breeds.
Three drugs, three different parasite targets, one tablet. Understanding what each component does helps you understand why vets ask the questions they do before prescribing.
Sarolaner is the isoxazoline compound and the first FDA-approved ingredient in this class (2016). It works by blocking GABA-gated chloride channels in invertebrates — essentially overstimulating the nervous system of fleas and ticks until they die. The selectivity for invertebrate receptors over mammalian ones is what makes it safe for dogs at label doses. The dose of sarolaner in Simparica Trio (1.2 mg/kg) is actually 40% lower than the dose in standalone Simparica chews (2.0 mg/kg) — a fact most owners don’t know. The combination product uses less of each individual ingredient than separate products would, which is part of why the safety profile looks the way it does. Sarolaner is the active ingredient that carries the FDA’s neurological class warning.
Moxidectin is a macrocyclic lactone, first approved by the FDA in 1997. It works by enhancing GABA and glutamate-gated chloride ion channel activity in parasites, causing paralysis and death of nematodes (worms). In the context of heartworm prevention, moxidectin kills heartworm larvae (L3 and L4 stages) that have been transmitted by mosquitoes during the previous 30 days — which is why monthly dosing is critical. Skipping a dose doesn’t mean the missed month is simply unprotected; it means larvae from that window can mature past the point moxidectin can kill. Moxidectin also has microfilaricidal activity against already-circulating larvae, which is why the heartworm test before starting matters. It is the ingredient that performs so well against ivermectin-resistant heartworm strains.
Pyrantel pamoate is the oldest of the three ingredients, first FDA-approved in 1977. It causes paralytic neuromuscular blockade in roundworms and hookworms — basically paralyzing them so they pass out of the intestinal tract. Roundworms (Toxocara canis) are the most common intestinal parasite in dogs and are a genuine public health concern, since the larvae are zoonotic — children playing in contaminated soil can become infected. Hookworms (Ancylostoma caninum) cause blood loss and anemia, particularly serious in puppies. Pyrantel handles both. One critical gap: pyrantel does not kill tapeworms, which require praziquantel. If your dog has tapeworms (identifiable as rice-grain segments near the tail), you’ll need a separate treatment.
- Tapeworms — requires praziquantel (found in Drontal, Droncit, or combination products like Interceptor Plus)
- Whipworms (Trichuris vulpis) — requires milbemycin oxime or fenbendazole; a common gap that surprises owners in high-risk areas
- Ear mites — requires a separate topical treatment
- Sarcoptic mange (scabies) — not indicated for Simparica Trio
- Cats — not approved for any use in felines
- Adult heartworms — it prevents, does not treat existing adult worm infections
The FDA’s approval document is specific about side effects. Knowing the difference between common, manageable reactions and the rarer neurological concerns helps you watch for the right things.
These are the adverse events that appeared in the controlled safety and effectiveness studies Zoetis submitted for FDA approval. In order of frequency: vomiting, diarrhea, lethargy, anorexia (reduced appetite), otitis externa (ear infection), pruritus (itching), polyuria (urinating more frequently), hyperactivity, and polydipsia (drinking more water). Most of these are mild and self-limiting — meaning they resolve on their own within 24–48 hours without treatment. Giving the chew with food reduces the likelihood of gastrointestinal side effects, though the product is labelled to be given with or without food.
The FDA’s isoxazoline class alert — which covers sarolaner, the flea-and-tick ingredient in Simparica Trio — identifies muscle tremors, ataxia (stumbling, loss of coordination), and seizures as potential adverse reactions. The agency is clear that these events were not observed in the approval studies, but were reported post-market across all isoxazoline products. The FDA also states that “seizures may occur in animals without a prior history.” What this means practically: the risk is real but uncommon, cannot always be predicted by a dog’s history, and requires updated labeling so vets and owners can make informed decisions. Dogs with pre-existing epilepsy, a history of any seizure activity, or known neurological conditions should be discussed individually with your vet before starting Simparica Trio.
The MDR1/ABCB1 gene mutation, most commonly found in Collies, Shetland Sheepdogs, Australian Shepherds, Border Collies, and a handful of other herding and related breeds, reduces P-glycoprotein function at the blood-brain barrier. Moxidectin — a macrocyclic lactone in Simparica Trio — is a P-glycoprotein substrate. Dogs with this mutation accumulate higher concentrations of moxidectin in the central nervous system than normal dogs, increasing neurotoxicity risk. Genetic testing for the ABCB1 mutation is available through veterinary genetic labs and costs roughly $70–$100. If your dog is a herding breed or herding breed mix, this conversation with your vet before starting any moxidectin-containing product is worth having.
If your dog vomits within 2 hours of taking Simparica Trio, contact your vet — the medication may not have been absorbed and your vet may want to re-dose. For any neurological symptoms — stumbling, muscle twitching, seizure activity — contact your vet or an emergency animal clinic immediately. To report an adverse event to the FDA: the FDA’s reporting portal for animal drugs is at fda.gov/safety/report-a-problem/report-adverse-events-animal-drugs. To report directly to the manufacturer, contact Zoetis at 888-963-8471. Keep the product packaging when you call so you have the lot number on hand.
The honest comparison — based on published studies and FDA-approved labeling, not marketing materials. Which product fits depends on what parasites are in your area and what your dog’s health history looks like.
| Product | Heartworm | Fleas | Ticks | Roundworm / Hookworm | Tapeworm | Frequency | Form |
|---|---|---|---|---|---|---|---|
| Simparica Trio | Yes (moxidectin) | Yes | 5 species | Yes (pyrantel) | No | Monthly | Oral chew |
| Heartgard Plus | Yes (ivermectin) | No | No | Yes (pyrantel) | No | Monthly | Oral chew |
| NexGard | No | Yes | Yes | No | No | Monthly | Oral chew |
| Interceptor Plus | Yes (milbemycin) | No | No | Yes | Yes (praziquantel) | Monthly | Oral chew |
| Bravecto | No | Yes | Yes | No | No | Every 12 weeks | Oral chew |
| Credelio Quattro | Yes (moxidectin) | Yes | Yes | Yes | Yes (praziquantel) | Monthly | Oral chew |
| ProHeart 12 | Yes (moxidectin) | No | No | No | No | Once per year | Injection |
Comparison based on FDA-approved label indications and published peer-reviewed studies. Resistant heartworm data from a laboratory study in Parasites & Vectors (2022). Always confirm current labeling with your veterinarian — products and indications change. This table is for educational purposes and not a substitute for veterinary advice.
Different dogs, different households, different circumstances. The right answer depends on more than what’s in the product — it depends on your specific dog’s history and your local parasite pressure.
Simparica Trio is a preventative, not a treatment for established adult heartworm infections. That said, a published study in Parasites & Vectors confirmed it was well tolerated in heartworm-positive dogs at both the label dose and three times the label dose. It reduced microfilaria counts significantly without causing clinical complications. This doesn’t mean you should start it without veterinary guidance — treatment for adult heartworms is a separate, multi-month protocol (melarsomine injections plus restricted activity) that Simparica Trio does not replace. Your vet may include Simparica Trio as part of the broader treatment plan, but the sequence and timing matter clinically.
This is one of the most important questions to ask your vet before starting Simparica Trio. The MDR1/ABCB1 gene mutation is common in Collies, Border Collies, Australian Shepherds, Shetland Sheepdogs, and a handful of other herding breeds and mixes. Dogs with the homozygous mutation (two copies) are most at risk for moxidectin neurotoxicity. Dogs with one copy (heterozygous) are at intermediate risk. Zoetis recommends consulting a veterinarian familiar with this breed-specific sensitivity before use. A genetic test (available through veterinary genetic labs for roughly $70–$100) can tell you definitively whether your dog carries the mutation. Some vets will prescribe Simparica Trio in confirmed non-mutant herding breed dogs without concern; others prefer to use ivermectin-based products regardless, given the lower neurotoxicity risk of ivermectin in MDR1 dogs.
This is a real emergency the first time it happens. Immediately contact your veterinarian or the nearest emergency animal clinic. Do not give another dose until you’ve had a thorough evaluation. Your vet needs to determine whether the seizure was caused by Simparica Trio or by an underlying condition (idiopathic epilepsy, toxin exposure, brain lesion, metabolic disease). Most first-time seizures in dogs have causes unrelated to medication, but Simparica Trio cannot be ruled out without a proper workup. Report the event to the FDA through fda.gov/safety/report-a-problem and to Zoetis at 888-963-8471. Alternative parasite protocols exist that avoid isoxazolines entirely — your vet can help build one.
Simparica Trio is approved for puppies eight weeks of age and older that weigh at least 2.8 pounds. At six weeks, your puppy is not yet eligible. Starting at eight weeks is important because the first dose of heartworm prevention establishes protection before the puppy has any mosquito exposure, and because roundworms are extremely common in puppies — many are born with them from the mother. The Companion Animal Parasite Council (CAPC) recommends beginning parasite prevention in puppies as early as the label allows, with fecal testing at the first puppy visit to assess existing worm burdens.
Yes — the liver-flavored chew is appealing to cats as well as dogs. A University of Nebraska-Lincoln academic review specifically identified cats in multi-pet households as the population most at risk for accidental Simparica Trio ingestion, noting that all three active ingredients are toxic to cats at canine dosing levels. Give the chew directly to the dog and supervise until it’s swallowed. Don’t leave unused chews within a cat’s reach. If accidental ingestion occurs: ASPCA Animal Poison Control Center at 888-426-4435 or your nearest emergency veterinarian immediately. Do not wait for symptoms to appear.
Simparica Trio requires a prescription in the United States. Where you fill that prescription can make a significant cost difference — sometimes more than 40% depending on the size of your dog.
Simparica Trio is available in six weight-based sizes. Monthly costs per dose vary roughly from $25 per month for the smallest dogs (2.8–5.5 lbs) to $35+ per month for the largest (88.1–132 lbs) when purchased in six-month supplies through online pharmacy channels like Walmart or Costco Pharmacy. Vet clinic retail pricing is typically 20–40% higher than pharmacy pricing for the same product. A GoodRx coupon can bring a 6-month supply of the most common sizes to approximately $180–$195 at participating pharmacies — roughly 7% off average retail. Buying a 12-month supply typically reduces the per-dose cost further compared to a 6-month supply.
Your vet writes the prescription; you can fill it anywhere. Costco Pharmacy members consistently report pricing for Simparica Trio well below vet clinic rates — one common figure cited by dog owners is roughly $120 for a 6-month supply for medium-sized dogs, versus $40 per month at a vet clinic for individual products. Walmart Pharmacy and Chewy Pet Pharmacy are both legal online pharmacies requiring valid prescriptions that often undercut vet clinic pricing. Ask your vet for a written prescription if they’re not the cheapest option — in most states, they are legally required to provide one upon request, though they may charge a nominal fee. Zoetis also runs a Simparica Trio rebate program periodically through their Petcare site — check simparicatrio.com for current offers.
Before starting Simparica Trio for the first time, most vets will require a heartworm antigen test — typically costing $35–$75 depending on the clinic and whether it’s run in-house or sent to a lab. This is not optional or upselling; it’s a genuine clinical requirement. Starting a moxidectin-containing product in a dog with a pre-existing adult heartworm infection can cause life-threatening complications. Annual heartworm testing is also recommended even for dogs on continuous prevention, because no preventative is 100% effective in real-world conditions (missed doses, vomiting up a chew, timing issues), and catching a breakthrough infection early vastly improves treatment outcomes.
These are the things vets want to explain but often don’t get the chance to because the appointment runs out of time — or because owners don’t know what to ask.
The specific date doesn’t matter as long as you’re consistent. Pick a memorable date — the first of the month, your dog’s birthday, a payday — and stick to it. What does matter is the interval: it should be no longer than 31 days. Heartworm larvae take approximately 30–35 days to develop past the stage where moxidectin can kill them. A dose that’s a week late in a high-mosquito area could leave a 5–7 day window where recently acquired larvae escape protection. Some vets recommend giving a dose a few days early rather than late to stay safely within the protective window.
This is a more common concern than most owners realize. Whether the active ingredients were absorbed depends on how quickly after administration the vomiting occurred. If vomiting happens within 30 minutes of administration, contact your vet — they may recommend re-dosing with a fresh chew, ideally given with food this time. If vomiting was delayed by more than an hour, absorption is likely sufficient and re-dosing is generally not recommended (to avoid double-dosing). Giving the chew at mealtime, embedded in food, or immediately after eating consistently reduces vomiting rates in practice.
Yes — transitioning from any monthly heartworm preventative to Simparica Trio is straightforward. Give the first Simparica Trio dose on the same day the next dose of the old product would have been due. No overlap period is needed. The one requirement: if you haven’t had a heartworm test within the past 12 months, get one before switching. This is especially true if there have been any gaps or late doses in the previous prevention schedule, since missed doses can allow heartworm larvae to mature past the preventable stage.
The American Heartworm Society recommends year-round heartworm prevention for all dogs in the United States regardless of climate. Mosquitoes — the sole vector of heartworm — can survive in heated indoor environments during winter months, and the occasional warm winter day can bring outdoor mosquito activity even in northern states. Year-round prevention also ensures continuity: if you plan to restart prevention each spring, the gap in winter leaves your dog partially unprotected during any unusual warm-weather mosquito activity. Additionally, the intestinal worm coverage (roundworm and hookworm) from the pyrantel component of Simparica Trio is year-round relevant — these parasites transmit regardless of season.
Most common dog medications are compatible with Simparica Trio, but this is always a conversation to have with your vet, not an assumption to make. The most significant interaction risk involves other drugs that are P-glycoprotein substrates — because moxidectin is also a P-gp substrate, co-administration of multiple P-gp substrates in MDR1-mutant dogs can compound neurotoxicity risk. In normal (non-mutant) dogs, Simparica Trio has been used alongside most common veterinary medications without reported interactions. Always disclose all supplements, flea preventatives, and prescription medications to your vet when starting Simparica Trio, including any topical spot-on products — you may be inadvertently doubling up on a class of insecticide if your dog is already using a sarolaner or afoxolaner collar or topical.
This page is for general educational purposes only and does not constitute veterinary medical advice. Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is manufactured by Zoetis and approved by the U.S. Food and Drug Administration. All clinical data and efficacy figures referenced are drawn from publicly available FDA approval documentation, peer-reviewed research published in scientific journals (including Parasites & Vectors), and University of Nebraska-Lincoln academic research. The FDA isoxazoline class alert referenced is a real, publicly available public health notice from the FDA’s Center for Veterinary Medicine. Always consult a licensed veterinarian before starting, stopping, or changing any medication for your dog. Pricing information reflects estimates based on publicly listed retail prices and is subject to change. The ASPCA Animal Poison Control Center (888-426-4435) charges a consultation fee. This content is not affiliated with, endorsed by, or sponsored by Zoetis or any retailer mentioned.